Cited by 1,076Biosensors and Analytical DetectionInnovation and Socioeconomic DevelopmentSARS-CoV-2 detection and testing

Point-of-Care Diagnostics for Global Health

Yager, Paul, Domingo, Gonzalo J., Gerdes, John·2008·Annual Review of Biomedical Engineering

Abstract

Biomedical engineers have traditionally developed technologies in response to the needs of the developed world's medical community. As a result, the diagnostic systems on which they have worked have met the requirements of well-funded laboratories in highly regulated and quality-assessed environments. However, such approaches do not address the needs of the majority of the world's people afflicted with infectious diseases, who have, at best, access to poorly resourced health care facilities with almost no supporting clinical laboratory infrastructure. A major challenge for the biomedical engineering community is to develop diagnostic tests to meet the needs of these people, the majority of whom are in the developing world. We here review the context in which the diagnostics must operate, some of the appropriate diagnostic technologies already in distribution, and some emerging technologies that promise to address this challenge. However, there is much room for innovation, adaptation, and cost reduction before these technologies can impact health care in the developing world.

Integrity signals

Registry

Crossref · 10.1146/annurev.bioeng.10.061807.160524

Cites

217 of 217 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Governments of India, Nepal, and Bangladesh pledged to eliminate visceral leishmaniasis by 2015, which along with improved treatment access prompted development of a simple point-of-care diagnostic tool detecting antibody agglutination.

    “The governments of India, Nepal, and Bangladesh pledged to eliminate visceral leishmaniasis by 2015, which along with improved treatment access, prompted the development of a simple point-of-care diagnostic tool which detects antibody agglutination”

    From Global Burden of Skin Disease: Inequities and Innovations (2017) · cites this paper as [45]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Yager, P., Domingo, G. J., & Gerdes, J.
Affiliations
  • University of Washington (US)
  • Program for Appropriate Technology in Health (US)
  • Redmond Fire Department (US)
Venue
Annual Review of Biomedical Engineering
Published
2008-08-01
Volume
10
Issue
1
Pages
107-144
ISSN
  • 1523-9829 (ISSN-L)
  • 1545-4274
OpenAlex
W2170895924
Cited by
1,076
References
217
Citations by year
2026: 34 · 2025: 43 · 2024: 47 · 2023: 58 · 2022: 55 · 2021: 55 · 2020: 89 · 2019: 56 · 2018: 65 · 2017: 73 · 2016: 72 · 2015: 87 · 2014: 79 · 2013: 78 · 2012: 51
FWCI
3.35
Type
journal article
Language
en
Open access
closed
Locations
  • Annual Review of Biomedical Engineering (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Biosensors and Analytical Detection
  • Social Sciences › Business, Management and Accounting › Business and International Management › Innovation and Socioeconomic Development
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
Keywords
point-of-care testing, global health, resource-limited settings, infectious diseases, diagnostic technology development, cost reduction, emerging diagnostic technologies
MeSH terms
Monitoring, Physiologic, Technology Assessment, Biomedical, Global Health, Point-of-Care Systems, Diagnostic Techniques and Procedures

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review